Annual Shareholders Equity
$7.73 M
-$3.11 M-28.68%
December 1, 2023
Summary
- As of February 7, 2025, PHIO annual stockholders equity is $7.73 million, with the most recent change of -$3.11 million (-28.68%) on December 1, 2023.
- During the last 3 years, PHIO annual shareholders equity has fallen by -$5.29 million (-40.62%).
- PHIO annual shareholders equity is now -64.75% below its all-time high of $21.93 million, reached on December 31, 2021.
Performance
PHIO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$4.95 M
+$1.17 M+31.09%
September 1, 2024
Summary
- As of February 7, 2025, PHIO quarterly stockholders equity is $4.95 million, with the most recent change of +$1.17 million (+31.09%) on September 1, 2024.
- Over the past year, PHIO quarterly shareholders equity has dropped by -$2.27 million (-31.43%).
- PHIO quarterly shareholders equity is now -84.25% below its all-time high of $31.40 million, reached on March 31, 2021.
Performance
PHIO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PHIO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.7% | -31.4% |
| 3 y3 years | -40.6% | -31.4% |
| 5 y5 years | -43.1% | -31.4% |
PHIO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.8% | at low | -77.5% | +31.1% |
| 5 y | 5-year | -64.8% | +34.5% | -84.3% | +31.1% |
| alltime | all time | -64.8% | +232.4% | -84.3% | +184.7% |
Phio Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.95 M(+31.1%) |
| Jun 2024 | - | $3.77 M(-32.7%) |
| Mar 2024 | - | $5.60 M(-27.5%) |
| Dec 2023 | $7.73 M(-28.7%) | $7.73 M(+7.2%) |
| Sep 2023 | - | $7.21 M(-27.2%) |
| Jun 2023 | - | $9.90 M(+35.5%) |
| Mar 2023 | - | $7.31 M(-32.5%) |
| Dec 2022 | $10.84 M(-50.6%) | $10.84 M(-19.9%) |
| Sep 2022 | - | $13.53 M(-20.4%) |
| Jun 2022 | - | $17.00 M(-12.6%) |
| Mar 2022 | - | $19.45 M(-11.3%) |
| Dec 2021 | $21.93 M(+68.5%) | $21.93 M(-13.1%) |
| Sep 2021 | - | $25.25 M(-12.5%) |
| Jun 2021 | - | $28.84 M(-8.1%) |
| Mar 2021 | - | $31.40 M(+141.2%) |
| Dec 2020 | $13.02 M(+126.5%) | $13.02 M(-15.8%) |
| Sep 2020 | - | $15.45 M(-12.9%) |
| Jun 2020 | - | $17.73 M(+48.0%) |
| Mar 2020 | - | $11.98 M(+108.5%) |
| Dec 2019 | $5.75 M(-57.7%) | $5.75 M(-24.4%) |
| Sep 2019 | - | $7.61 M(-21.7%) |
| Jun 2019 | - | $9.71 M(-16.8%) |
| Mar 2019 | - | $11.66 M(-14.1%) |
| Dec 2018 | $13.58 M | $13.58 M(+675.9%) |
| Sep 2018 | - | $1.75 M(-46.5%) |
| Jun 2018 | - | $3.27 M(+477.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $567.00 K(-69.1%) |
| Dec 2017 | $1.83 M(-83.1%) | $1.83 M(-46.6%) |
| Sep 2017 | - | $3.43 M(-42.2%) |
| Jun 2017 | - | $5.94 M(-28.0%) |
| Mar 2017 | - | $8.25 M(-24.0%) |
| Dec 2016 | $10.86 M(+22.1%) | $10.86 M(+257.5%) |
| Sep 2016 | - | $3.04 M(-38.9%) |
| Jun 2016 | - | $4.97 M(-28.5%) |
| Mar 2016 | - | $6.95 M(-21.8%) |
| Dec 2015 | $8.89 M(+223.9%) | $8.89 M(-19.4%) |
| Sep 2015 | - | $11.03 M(-16.0%) |
| Jun 2015 | - | $13.13 M(+419.4%) |
| Mar 2015 | - | $2.53 M(-7.9%) |
| Dec 2014 | $2.75 M(-44.5%) | $2.75 M(-41.9%) |
| Sep 2014 | - | $4.72 M(-28.0%) |
| Jun 2014 | - | $6.56 M(+5.5%) |
| Mar 2014 | - | $6.22 M(+25.8%) |
| Dec 2013 | $4.94 M(-184.6%) | $4.94 M(-29.9%) |
| Sep 2013 | - | $7.05 M(+5.0%) |
| Jun 2013 | - | $6.71 M(-17.3%) |
| Mar 2013 | - | $8.12 M(-239.0%) |
| Dec 2012 | -$5.84 M(+894.9%) | -$5.84 M(+36.6%) |
| Sep 2012 | - | -$4.27 M(+54.0%) |
| Jun 2012 | - | -$2.78 M(+56.2%) |
| Mar 2012 | - | -$1.78 M(+202.7%) |
| Dec 2011 | -$587.00 K | -$587.00 K |
FAQ
- What is Phio Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals annual shareholders equity year-on-year change?
- What is Phio Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Phio Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of PHIO is $7.73 M
What is the all time high annual shareholders equity for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high annual stockholders equity is $21.93 M
What is Phio Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, PHIO annual stockholders equity has changed by -$3.11 M (-28.68%)
What is Phio Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of PHIO is $4.95 M
What is the all time high quarterly shareholders equity for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high quarterly stockholders equity is $31.40 M
What is Phio Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, PHIO quarterly stockholders equity has changed by -$2.27 M (-31.43%)